Crosspoint Capital Strategies, LLC Incyte Corp Transaction History

Crosspoint Capital Strategies, LLC

  • $50.4 Million
  • Q4 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 14, 2018
SELL
$83.06 - $100.98 $684,331 - $831,974
-8,239 Closed
0 $0
Q4 2017

Feb 13, 2018
SELL
$93.56 - $116.6 $65,959 - $82,203
-705 Reduced 7.88%
8,239 $7.8 Million
Q3 2017

Nov 06, 2017
BUY
$109.15 - $138.27 $976,237 - $1.24 Million
8,944
8,944 $1.04 Million

Others Institutions Holding INCY

# of Institutions
643
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.3B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Crosspoint Capital Strategies, LLC Portfolio

Follow Crosspoint Capital Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crosspoint Capital Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crosspoint Capital Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email